FI943642A - Sulfatoidut polysakkaridit, menetelmä niiden valmistamiseksi, farmaseuttinen valmistus ja käyttö - Google Patents

Sulfatoidut polysakkaridit, menetelmä niiden valmistamiseksi, farmaseuttinen valmistus ja käyttö Download PDF

Info

Publication number
FI943642A
FI943642A FI943642A FI943642A FI943642A FI 943642 A FI943642 A FI 943642A FI 943642 A FI943642 A FI 943642A FI 943642 A FI943642 A FI 943642A FI 943642 A FI943642 A FI 943642A
Authority
FI
Finland
Prior art keywords
preparation
sulfated polysaccharides
pharmaceutical preparation
pharmaceutical
daltons
Prior art date
Application number
FI943642A
Other languages
English (en)
Swedish (sv)
Other versions
FI106034B (fi
FI943642A0 (fi
Inventor
Andre Uzan
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI943642A publication Critical patent/FI943642A/fi
Publication of FI943642A0 publication Critical patent/FI943642A0/fi
Application granted granted Critical
Publication of FI106034B publication Critical patent/FI106034B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
FI943642A 1992-02-07 1994-08-05 Menetelmä sulfatoitujen polysakkaridien terapeuttisesti käyttökelpoisen seoksen valmistamiseksi FI106034B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9201383 1992-02-07
FR9201383A FR2687158B1 (fr) 1992-02-07 1992-02-07 Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.
FR9300114 1993-02-04
PCT/FR1993/000114 WO1993016112A1 (fr) 1992-02-07 1993-02-04 Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation

Publications (3)

Publication Number Publication Date
FI943642A true FI943642A (fi) 1994-08-05
FI943642A0 FI943642A0 (fi) 1994-08-05
FI106034B FI106034B (fi) 2000-11-15

Family

ID=9426428

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943642A FI106034B (fi) 1992-02-07 1994-08-05 Menetelmä sulfatoitujen polysakkaridien terapeuttisesti käyttökelpoisen seoksen valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0625166B1 (fi)
JP (1) JP3218039B2 (fi)
KR (1) KR950700334A (fi)
AT (1) ATE157991T1 (fi)
AU (1) AU671817B2 (fi)
CA (1) CA2126241C (fi)
DE (1) DE69313826T2 (fi)
DK (1) DK0625166T3 (fi)
ES (1) ES2109478T3 (fi)
FI (1) FI106034B (fi)
FR (1) FR2687158B1 (fi)
GR (1) GR3024695T3 (fi)
HU (1) HU214327B (fi)
MX (1) MX9300584A (fi)
NO (1) NO307466B1 (fi)
NZ (1) NZ249165A (fi)
WO (1) WO1993016112A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
US6075013A (en) * 1997-06-06 2000-06-13 Hamilton Civic Hospitals Research Development Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP2404939A3 (en) 2006-05-25 2012-03-21 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CA3020369C (en) * 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945595A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen
FR2622450B1 (fr) * 1987-11-03 1991-02-22 Sanofi Sa Association heparine/dermatane sulfate
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2675806B1 (fr) * 1991-04-23 1994-06-10 Rhone Poulenc Rorer Sa Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.

Also Published As

Publication number Publication date
NO307466B1 (no) 2000-04-10
FR2687158A1 (fr) 1993-08-13
AU3505193A (en) 1993-09-03
FR2687158B1 (fr) 1995-06-30
DE69313826D1 (de) 1997-10-16
ES2109478T3 (es) 1998-01-16
FI106034B (fi) 2000-11-15
DE69313826T2 (de) 1998-02-12
NZ249165A (en) 1996-01-26
CA2126241C (fr) 2004-06-22
HU214327B (hu) 1998-03-02
HUT67878A (en) 1995-05-29
ATE157991T1 (de) 1997-09-15
AU671817B2 (en) 1996-09-12
GR3024695T3 (en) 1997-12-31
MX9300584A (es) 1993-08-01
NO942897D0 (fi) 1994-08-04
NO942897L (no) 1994-08-04
HU9401994D0 (en) 1994-09-28
KR950700334A (ko) 1995-01-16
JPH07503496A (ja) 1995-04-13
EP0625166A1 (fr) 1994-11-23
EP0625166B1 (fr) 1997-09-10
WO1993016112A1 (fr) 1993-08-19
DK0625166T3 (da) 1998-02-02
JP3218039B2 (ja) 2001-10-15
CA2126241A1 (fr) 1993-08-19
FI943642A0 (fi) 1994-08-05

Similar Documents

Publication Publication Date Title
IL61201A (en) Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
IL98604A0 (en) Mixtures of low molecular weight polysaccharides,their preparation and pharmaceutical compositions containing them
IL62424A (en) Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them
FI943642A (fi) Sulfatoidut polysakkaridit, menetelmä niiden valmistamiseksi, farmaseuttinen valmistus ja käyttö
FI103381B1 (fi) Hyaluronihapon veteen liukenemattomia geelejä ja menetelmä sen valmistamiseksi
NZ224275A (en) Low molecular weight heparin derivatives; pharmaceutical compositions
EA199700347A1 (ru) Сульфатированный олигосахарид, его применение для лечения теплокровных животных и фармацевтическая композиция на его основе
EE03608B1 (et) Taksoidid, meetod nende valmistamiseks ja neid sisaldavad farmatseutilised kompositsioonid
FI915697A (fi) N,o-sulfaterade heparosaner, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande dem.
EE03929B1 (et) Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
IT1238685B (it) Polisaccaridi ad azione immunomodulatrice da astragalus membranaceous e composizioni farmaceutiche che li contengono
IL99294A0 (en) Indolonaphthyridines,their production and pharmaceutical compositions containing them
ZA922874B (en) Sulphated polysaccharides,their preparation,pharmaceutical compositions containing them and their use
GB2235198B (en) Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same
BR8803856A (pt) Derivados da piridina substituidos,processo para sua preparacao,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes
IL93719A0 (en) (5(6)(benzisoxa-benzisothia-or indazol-3-yl)-1h-benzimidazol-2-yl)carbamates,their preparation and pharmaceutical compositions containing them
ATE213000T1 (de) Nichtabsorbierbare, synthetische, sulfatierte polysaccharide
IL70406A (en) Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin
IT1243921B (it) Derivati di selenofene, un procedimento per la loro preparazione e composizioni che li contengono.
NO178728C (no) Fremgangsmåte for fremstilling av et sulfatert lignin
IL106354A0 (en) Pharmaceutical or veterinary compositions containing a sulfated polysaccharide for anti-inflammatory treatment
IT8953345V0 (it) Dondolo da giardino
IT8820226A0 (it) Fosfatidil n_acetil_l_serina, composizioni farmaceutiche che la contengono e processo per la sua preparazione.

Legal Events

Date Code Title Description
MA Patent expired